Related Experiment Video
Updated: Jul 3, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Treating prehypertension: a review of the evidence
1University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 25390, USA. norman.kaplan@utsouthwestern.edu
Insights
Prehypertension, defined as blood pressure between 120/80 and 139/89 mm Hg, affects many individuals at increased cardiovascular risk. Optimal management strategies for prehypertension remain under investigation, with limited outcome data available.
Area of Science:
- Cardiology
- Public Health
Background:
- The term "prehypertension" describes individuals with elevated blood pressure (BP) readings, specifically systolic BP between 120-139 mm Hg and/or diastolic BP between 80-89 mm Hg.
- This category encompasses a significant population, comparable in number to those diagnosed with hypertension (BP ≥ 140/90 mm Hg).
- Individuals in the prehypertension range face a demonstrably higher risk of cardiovascular damage compared to those with normal BP (<120/80 mm Hg).
Purpose of the Study:
- To review the current understanding and acceptance of the "prehypertension" classification.
- To highlight the increased cardiovascular risk associated with prehypertension.
- To identify the key unresolved issue regarding the management of patients with prehypertension.
Main Methods:
- Literature review and synthesis of existing clinical trial data.
- Analysis of the epidemiological significance of the prehypertension category.
- Examination of the current evidence for therapeutic interventions.
Main Results:
- The classification of prehypertension (BP 120-139/80-89 mm Hg) has gained general acceptance despite some debate.
- Prehypertension affects a large population, similar in size to the hypertensive population.
- Individuals with prehypertension exhibit increased cardiovascular risk compared to those with normal BP.
Conclusions:
- The primary challenge in managing prehypertension lies in determining the appropriate therapeutic strategies.
- While short-term drug therapy trials exist to assess BP progression, outcome studies are currently lacking.
- Further research is needed to establish evidence-based management guidelines for prehypertension to mitigate long-term cardiovascular risks.
Abstract:
Although the term "prehypertension" has been challenged by some, its use to define people with systolic blood pressure (BP) between 120 and 139 mm Hg and/or diastolic pressures between 80 and 89 mm Hg has gained general acceptance. The category includes as many people as the number who have hypertension, defined as blood pressure of 140/90 or above. Such people are clearly at an increased risk of cardiovascular damage compared with people with BPs below 120/80 mm Hg. The major unresolved issue is the appropriate management of such patients. Two trials have attempted to document the value of short-term drug therapy to prevent the progression of BP to overt hypertension, but no outcome studies are currently available.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction